Subject to change
| print this page | |||
| FRIDAY JUNE 21, 2002 |
SATURDAY JUNE 22, 2002 |
SUNDAY JUNE 23, 2002 |
List of Poster Presentations |
FRIDAY, JUNE 21, 2002
| 08:00 - 10:00 | Hall A |
| OPENING SESSION - MEDICAL ECONOMICS Congressional and ACOG representation Chairpersons: R. Lobo, USA A. Decherney, USA |
|
| GOVERNMENT INVOLVEMENT IN HEALTH AND HUMAN
SERVICES Congressman H.A. Waxman, USA |
|
| OB/GYN CANNOT MAKE A LIVING
IN AMERICA TODAY / MANAGED CARE S.B. Williams, USA |
|
| WORKFORCE IN OB/GYN - GENDER
ISSUES W. Pearse, USA |
|
| 10:30 - 12:30 | Hall A |
| CEREBRAL
PALSY Chairpersons: G. Hankins, USA M. D'Alton, USA |
|
| Capsule: With so many uncertainties and without tools to detect it prenatlly, we need more data to prevent this costly complication |
|
| NEONATAL ENCEPHALOPATHY AND
THE OBSTETRICIAN - THE REVISED ACOG CRITERIA G. Hankins, USA |
|
| NEUROLOGIC COMPLICATIONS IN
MULTIPLE PREGNANCY - IS IT POSSIBLE TO REDUCE THE INCIDENCE? WHAT
ARE THE IMPLICATIONS FOR PRACTICE? M. D'Alton, USA |
|
| EMERGING ISSUES IN CEREBRAL
PALSY - THE ROLE OF INFECTION - WHAT ARE THE IMPLICATIONS FOR CLINICAL
PRACTICE? G. Saade, USA |
|
| THE BRAIN DAMAGED BABY - IMPLICATIONS
FOR THE OBSTETRICIAN R. Berkowitz, USA |
|
| 10:30 - 12:30 | Hall B |
| THE GONADOTROPIN
CHRONICLES: CONTROVERSY OR CONSENSUS? Sponsored by Serono Chairperson: Z. Rosenwaks, USA |
|
| Capsule: Controversy exists regarding the relative differences between recombinant and urinary gonadotropin products. How important are these differences and are they clinically relevant? |
|
| CHARACTERIZING RECOMBINANT
AND URINARY GONADOTROPINS J. Dias, USA |
|
| PRECISE DOSING OF RECOMBINANT
FSH THROUGH MANUFACTURING IMPROVEMENTS E. Loumaye, USA |
|
| THE PATIENT PERSPECTIVE: TAILORING
TREATMENT WITHOUT SACRIFICING EFFICACY A. Penzias, USA |
|
| 10:30 - 12:30 | Hall C |
| SERMs Sponsored by Eli Lilly Chairperson: M. Notelovtiz, USA J. Cauley, USA |
|
| Capsule: Can SERMs provide an answer for HRT drawbacks? How strong is the evidence? |
|
| OSTEOPOROSIS S. Silverman, USA |
|
| CAN BREAST CANCER BE PREVENTED? J. Cauley, USA |
|
| SERMs AND CARDIOVASCULAR HEALTH L. Mosca, USA |
|
| GYNECOLOGICAL CONSIDERATIONS S. Hendrix, USA |
|
| 13:30 - 15:30 | Hall A |
| FETAL
SURVEILLANCE Chairpersons: N. Fisk, UK R. Berkowitz, USA |
|
| Capsule: Does fetal surveillance improve fetal outcome? |
|
| HOW MUCH DOES FETAL MONITORING
INCREASE THE C-SECTION RATE? M. Socol, USA |
|
| HOW TO AVOID MISUSE OF THE
BIOPHYSICAL PROFILE L. Platt, USA |
|
| DOES DOPPLER ULTRASOUND IMPROVE
OUTCOME IN THE MANAGEMENT OF THE GROWTH - RESTRICTED FETUSES? A. Abuhamad, USA |
|
| FETAL PULSE OXIMETRY - DOES
IT HAVE A ROLE? G. Saade, USA |
|
| DOES 3-D ULTRASOUND CONTRIBUTE
SIGNIFICANTLY TO THE CURRENT METHODS OF ANOMALY DETECTION? L. Platt, USA |
|
| 13:30 - 15:30 | Hall B |
| ENDOMETRIOSIS Chairpersons: P.R. Koninckx, Belgium S. Daya, Canada |
|
| Capsule: A perplexing, poorly understood disease of the female reproductive system |
|
| SURGERY Vs. MEDICAL THERAPY:
SURGICAL APPROACH P.R. Koninckx, Belgium |
|
| SURGERY Vs. MEDICAL THERAPY:
MEDICAL APPROACH K.W. Schweppe, Germany |
|
| TREATMENT FOR MILD/MINIMAL
DISEASE R.S. Schenken, USA |
|
| IS IVF THE ANSWER FOR INFERTILITY
- STAGE/SUCCESS RATES Z. Rosenwaks, USA |
|
| RECTOVAGINAL ENDOMETRIOSIS
PREFERRED TREATMENT P.R. Koninckx, Belgium |
|
| 13:30 - 15:30 | Hall C |
| OVARIAN
CANCER: SCREENING AND PROPHYLACTIC OOPHORECTOMY Chairpersons: P. Schwartz, USA L. Platt, USA |
|
| Capsule: Delayed diagnosis of ovarian cancer is the major problem affecting prognosis - Can we diagnose it earlier? |
|
| SONOGRAPHY FOR EARLY DIAGNOSIS
- MASS SCREENING L. Platt, USA |
|
| THE PLACE OF BIOCHEMICAL TESTING D.A. Fishman, USA |
|
| INCIDENTAL PROPHYLACTIC OOPHORECTOMY
DURING ABDOMINAL SURGERY P.E. Schwartz, USA |
|
| THE ROLE OF GENETIC TESTING
FOR BREAST AND OVARIAN CANCER - IS IT A RESEARCH OR A CLINICAL TOOL? H. Gallion, USA |
|
| 16:00 - 18:00 | Hall A |
| THROMBOPHILIA
IN OBSTETRICS AND GYNECOLOGY Chairpersons: D. Blickstein, Israel G. Saade, USA |
|
| Capsule: Screening for Thrombophilia may be useful in preventing complications |
|
| WHAT IS THE EVIDENCE FOR THE
RELATION TO ADVERSE PREGNANCY OUTCOME? M. Paidas, USA |
|
| SHOULD WE SCREEN WOMEN FOR
THROMBOPHILIA IN OBSTETRICS AND GYNECOLOGY? B. Konkle, USA |
|
| IS THERE ROOM FOR LMWH TREATMENT
IN OB/GYN? D. Blickstein, Israel |
|
| THROMBOPHILIA 2002 - OVERVIEW G. Saade, USA |
|
| 16:00 - 18:00 | Hall B |
| WORKUP
OF INFERTILITY Chairpersons: R.S. Schenken, USA R. Scott, USA |
|
| Capsule: Are all diagnostic procedures really important before IVF or can we do without them? |
|
| SALPINGOSCOPY, MICROSALPINGOSCOPY,
HYSTEROSCOPY AND HSG: DO WE NEED THEM ALL ? H. Verhoeven, Germany |
|
| WHEN IS INFERTILITY SURGERY
INDICATED? J. Rock, USA |
|
| SIMPLE SPERM ANALYSIS IS ALL
WE NEED S. Oehninger, USA |
|
| IVF SHOULD BE THE FIRST LINE
OF DIAGNOSIS AND TREATMENT R. Scott, USA |
|
| 16:00 - 18:00 | Hall C |
| THE CURRENT PLACE OF LAPAROSCOPIC
SURGERY IN GYNECO-ONCOLOGY Chairpersons: P. Schwartz, USA N. Spirtos, USA |
|
| Capsule: Laparoscopic surgery in Gyneco-Oncology - is laparotomy over? |
|
| BORDERLINE OVARIAN TUMORS:
SHOULD THEY BE TREATED BY LAPAROTOMY OR LAPAROSCOPY? N. Spirtos, USA |
|
| SHOULD LAPARASCOPY BE USED
FOR SURGICAL STAGING IN CERVICAL CANCER? P. Dottino, USA |
|
| WHAT IS THE ROLE OF LAPARASCOPIC
SURGERY IN OVARIAN CANCER? N. Abu-Rustum, USA |
|
| SHOULD LAPARASCOPY
BE THE ULTIMATE SURGICAL PROCEDURE FOR ENDOMETRIAL CANCER? P. Dottino, USA |
|
| LAPAROSCOPIC SURGERY: DOES
IT APPLY TO ALL TYPES OF GYNECOLOGICAL CANCER AND TO ALL STAGES? DOES
IT IMPROVE DIAGNOSIS? N. Abu-Rustum, USA |
|
| FRIDAY JUNE 21, 2002 |
SATURDAY JUNE 22, 2002 |
SUNDAY JUNE 23, 2002 |
List of Poster Presentations |